IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank75
3Y CAGR+60.7%
5Y CAGR+6.1%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+60.7%/yr
vs -37.9%/yr prior
5Y CAGR
+6.1%/yr
Recent acceleration
Acceleration
+98.6pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 78.52% |
| 2024 | 45.97% |
| 2023 | 11.48% |
| 2022 | 18.93% |
| 2021 | 32.77% |
| 2020 | 58.53% |
| 2019 | 130.22% |
| 2018 | 127.42% |
| 2017 | 0.00% |